Clincosm LogoSign in Get a demo

metastatic uveal melanoma

Showing 1 - 25 of 26
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Nov 2, 2023

Metastatic Uveal Melanoma Trial in Grand Rapids (IDE196, Crizotinib, Pembrolizumab)

Recruiting
  • Metastatic Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Aug 14, 2023

Acral Lentiginous Melanoma, CNS Melanoma, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial in Houston (Nivolumab)

Active, not recruiting
  • Acral Lentiginous Melanoma
  • +9 more
  • Biospecimen Collection
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2023

Metastatic Uveal Melanoma Trial in Westmead (DYP688)

Recruiting
  • Metastatic Uveal Melanoma
  • Boston, Massachusetts
  • +8 more
Jan 31, 2023

Metastatic Uveal Melanoma Trial in France, Netherlands, United States (FHD-286)

Recruiting
  • Metastatic Uveal Melanoma
  • Los Angeles, California
  • +10 more
Jan 29, 2023

Metastatic Uveal Melanoma Trial in Philadelphia (Defactinib Hydrochloride, Raf/MEK Inhibitor VS-6766)

Recruiting
  • Metastatic Uveal Melanoma
  • Defactinib Hydrochloride
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • Metastatic Uveal Melanoma
  • Aldesleukin
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 20, 2023

Advanced Uveal Melanoma, Metastatic Uveal Melanoma, Unresectable Uveal Melanoma Trial (BRD4 Inhibitor PLX2853, Trametinib,

Not yet recruiting
  • Advanced Uveal Melanoma
  • +2 more
  • BRD4 Inhibitor PLX2853
  • +4 more
  • (no location specified)
Jan 9, 2023

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Choroidal and Ciliary Body Melanoma AJCC V8 Trial

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson Univeristy
Nov 16, 2022

Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))

Recruiting
  • Uveal Melanoma
  • +3 more
  • Lifileucel (LN-144)
  • Harrison, New York
  • +1 more
Nov 8, 2022

Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan,

Not yet recruiting
  • Metastatic Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Oct 14, 2022

Metastatic Uveal Melanoma Trial in Miami (Nivolumab, Relatlimab)

Recruiting
  • Metastatic Uveal Melanoma
  • Miami, Florida
    University of Miami Sylvester Comprehensive Cancer Center
Aug 23, 2022

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in Philadelphia

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +2 more
  • Ipilimumab
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Aug 15, 2022

Metastatic Uveal Melanoma Trial in Paris (Pembrolizumab 25 MG/1 ML Intravenous Solution)

Recruiting
  • Metastatic Uveal Melanoma
  • Pembrolizumab 25 MG/1 ML Intravenous Solution
  • Paris, France
    Institut Curie
Aug 3, 2022

Metastatic Esophageal, Gastric Cancer, Metastatic Head and Neck Carcinoma Trial in Houston (LVGN3616 + LVGN6051 +

Recruiting
  • Metastatic Esophageal
  • +7 more
  • LVGN3616 + LVGN6051 + Nab-Paclitaxel
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in New York, Nashville (Laboratory Biomarker Analysis,

Active, not recruiting
  • Metastatic Uveal Melanoma
  • Stage IV Uveal Melanoma AJCC v7
  • New York, New York
  • +2 more
Jun 29, 2022

Metastatic Uveal Melanoma Trial in Tampa (Binimetinib, Belinostat)

Recruiting
  • Metastatic Uveal Melanoma
  • Tampa, Florida
    Moffitt Cancer Center
Jun 21, 2022

Metastatic Uveal Melanoma, Cutaneous Melanoma, Colorectal Cancer Trial in Australia, Canada, United States (IDE196, Binimetinib,

Recruiting
  • Metastatic Uveal Melanoma
  • +3 more
  • Scottsdale, Arizona
  • +13 more
May 10, 2022

Metastatic Uveal Melanoma, Triple Negative Breast Cancer, Luminal B Breast Cancer Trial in Paris (Questionnaires,

Recruiting
  • Metastatic Uveal Melanoma
  • +3 more
  • Questionnaires
  • +3 more
  • Paris, France
    Institut Curie
Apr 6, 2022

Cancer Metastatic to the Liver, Hepatocellular Carcinoma, Metastatic Melanoma Trial in United States (PV-10 (10% rose bengal

Recruiting
  • Cancer Metastatic to the Liver
  • +9 more
  • PV-10 (10% rose bengal disodium)
  • San Diego, California
  • +4 more
Mar 22, 2022

Metastatic Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7 Trial in Houston (Ipilimumab, Laboratory Biomarker Analysis,

Unknown status
Has Results
  • Metastatic Uveal Melanoma
  • Stage IV Uveal Melanoma AJCC v7
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2020

Lung Squamous Cell Carcinoma Stage IV, Nonsquamous Nonsmall Cell Tumor of Lung, Metastatic Uveal Melanoma Trial in Houston

Terminated
  • Lung Squamous Cell Carcinoma Stage IV
  • +2 more
  • ADV/HSV-tk
  • +3 more
  • Houston, Texas
    Houston Methodist Hospital
Nov 17, 2020

Metastatic Uveal Melanoma Trial in Wirral (Dacarbazine, Sunitinib)

Completed
  • Metastatic Uveal Melanoma
  • Wirral, United Kingdom
    Clatterbridge Centre for Oncology NHS Foundation Trust
Oct 27, 2019

Metastatic Uveal Melanoma Trial in Gothenburg (Pembrolizumab, Entinostat)

Active, not recruiting
  • Metastatic Uveal Melanoma
  • Gothenburg, Västra Götaland Region, Sweden
    Department of oncology, Sahlgrenska University Hospital
Oct 15, 2019

Metastatic Ocular Melanoma, Metastatic Uveal Melanoma Trial run by the NCI (Aldesleukin, Cyclophosphamide, Fludarabine)

Terminated
Has Results
  • Metastatic Ocular Melanoma
  • Metastatic Uveal Melanoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 10, 2018